PeptiDream Inc. (TYO:4587)
Japan
· Delayed Price · Currency is JPY 1,748.00
-27.50 (-1.55%)
May 16, 2025, 3:30 PM JST
PeptiDream Revenue
PeptiDream had revenue of 4.23B JPY in the quarter ending March 31, 2025, with 0.19% growth. This brings the company's revenue in the last twelve months to 46.68B, up 66.88% year-over-year. In the year 2024, PeptiDream had annual revenue of 46.68B with 62.57% growth.
Revenue (ttm)
46.68B
Revenue Growth
+66.88%
P/S Ratio
4.85
Revenue / Employee
75.18M
Employees
621
Market Cap
226.56B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 46.68B | 17.96B | 62.57% |
| Dec 31, 2023 | 28.71B | 1.86B | 6.93% |
| Dec 31, 2022 | 26.85B | 17.49B | 186.70% |
| Dec 31, 2021 | 9.37B | -2.31B | -19.79% |
| Dec 31, 2020 | 11.68B | 9.60B | 462.85% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
| Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Daiichi Sankyo Company | 1,886.26B |
| Takeda Pharmaceutical Company | 4,581.55B |
| HOYA Corporation | 869.37B |
| Terumo | 1,011.15B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Olympus | 993.33B |